European Union: Radium Ra 223 dichloride for the treatment of castration-resistant prostate cancer with bone metastases, CHMP recommended the approval
Bayer HealthCare has announced that the European Committee for Medicinal Products for Human Use ( CHMP ) recommended Radium Ra 223 dichloride ( Radium-223; Xofigo ) for approval with a proposed indica ...
read article